Anika Therapeutics | ANIK - Interessi Passivi Sul Debito





Interessi Passivi Sul Debito Cambiamento Data
Abbott USD 297M 2M 2026-09
Agenus USD 14.67M 1.35M 2026-03
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Anika Therapeutics 183.47M 4.09M 2026-06
Arrowhead Research USD 24.56M 716K 2026-06
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Halozyme Therapeutics USD 6.04M 457K 2026-09
Heron Therapeutics USD 600K 100K 2024-12
Insmed USD 20.41M 1.57M 2026-09
Integra LifeSciences USD 22.96M 33K 2026-09
Intrexon USD 2K 5K 2024-06
J&J USD 43M 25M 2026-03
Karyopharm Therapeutics USD 12.55M 66K 2026-03
Ligand Pharmaceuticals USD 1.78M 875K 2025-12
MacroGenics USD 4.4M 493K 2026-06
Merit Medical Systems USD 7.33M 4.78M 2026-09
Rigel Pharmaceuticals USD 2.06M 31K 2024-09
Sangamo BioSciences 97.56M 11.39M 2025-06
Sanofi EUR 222M 65M 2026-09
Smith & Nephew USD 69M 1000K 2025-12
Stryker USD 47.25B 683M 2026-09
Veracyte USD 2K 1000 2023-12
Xencor USD 4.11M 3.24M 2026-09
Zimmer Biomet Holdings USD 23.54B 740.8M 2026-09